サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1407982

連続バイオプロセシングの世界市場規模調査・予測：製品別、用途別、エンドユーザー別、地域別分析、2023-2030年

Global Continuous Bioprocessing Market Size study & Forecast, by Product, by Application, by End User and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
連続バイオプロセシングの世界市場規模調査・予測：製品別、用途別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年12月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の連続バイオプロセシング市場は、2022年に約1億2,560万米ドルと評価され、予測期間2023-2030年には22.50%以上の健全な成長率で成長すると予測されています。

連続バイオプロセシングは、従来のバッチ処理とは対照的に、生物学的製剤の製造工程が中断することなく行われるバイオ医薬品業界の製造方法を指します。連続バイオプロセシング市場は、受託開発・製造機関の増加やバイオ医薬品需要の高まりなどの要因により拡大しています。連続バイオプロセシングのセットアップでは、細胞培養、収穫、精製、製剤化といった生産プロセスのさまざまな段階が、個別のバッチとして実施されるのではなく、連続的なフローで接続されます。その結果、2023-2030年の予測期間中、国際市場では連続バイオプロセシングの需要が徐々に増加しています。

連続バイオプロセシングは、リソースの利用率を向上させ、ダウンタイムを最小限に抑え、生産プロセスを最適化することで、製造コスト全体を削減する可能性を秘めています。CDMOはサービスプロバイダーとして、顧客に費用対効果の高いソリューションを提供することに重点を置くことが多いです。Statistaによると、CDMO（Contract Development and Manufacturing Organization）市場は2020年に1,155億米ドルを占め、2030年には2,235億米ドルに達すると予測されています。連続バイオプロセシング市場を牽引するもう一つの重要な要因は、バイオ医薬品需要の増加です。連続バイオプロセシングは、製品の品質と一貫性の向上に貢献します。リアルタイムのモニタリングと制御メカニズムは、望ましい製品属性を維持する能力を強化し、ばらつきを抑えて高品質のバイオ医薬品を確保します。さらに、Statistaによると、2022年の世界の医薬品市場は1兆4,800億米ドルを占めます。これは、市場が1兆4,200億米ドルと評価された2021年からわずかな増加です。さらに、開発・製造受託機関の増加やバイオ医薬品に対する需要の高まりは、予測期間中に同市場に有利な成長機会をもたらすと予想されます。しかし、高額な設備投資と厳しい規制要件が、2023～2030年の予測期間を通じて市場全体の成長を阻害することになるでしょう。

連続バイオプロセシングの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、バイオ製薬企業が同地域での市場プレゼンスを拡大するために戦略的パートナーシップや提携を結んでいることから、2022年の市場を独占しました。この地域の圧倒的な実績は、連続バイオプロセシングの全体的な需要を促進すると予想されます。さらに、アジア太平洋地域は、バイオプロセシング技術やパートナーシップの拡大、同地域のバイオ医薬品製造の主要企業との提携などの要因により、予測期間中に最も急成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の連続バイオプロセシング市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界の連続バイオプロセシング市場力学

  • 連続バイオプロセシング市場の影響分析（2020～2030年）
    • 市場促進要因
      • 開発・製造受託機関の増加
      • バイオ医薬品需要の増加
    • 市場の課題
      • 高額な設備投資
      • 厳しい規制要件
    • 市場機会
      • 統合されたエンド・ツー・エンドの連続バイオプロセシングの台頭
      • 連続バイオプロセシングの革新的技術に対する政府の支援イニシアティブ

第4章 世界の連続バイオプロセシング市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 連続バイオプロセシングの世界市場：製品別

  • 市場スナップショット
  • 連続バイオプロセシングの世界市場：製品別、実績 - ポテンシャル分析
  • 連続バイオプロセシングの世界市場：製品別推定・予測、2020～2030年
  • 連続バイオプロセシング市場、サブセグメント分析
    • ろ過システム・消耗品
    • クロマトグラフィーシステム・消耗品
    • バイオリアクター
    • 滅菌器
    • 遠心分離機
    • その他

第6章 連続バイオプロセシングの世界市場：用途別

  • 市場スナップショット
  • 連続バイオプロセシングの世界市場：用途別、実績 - ポテンシャル分析
  • 連続バイオプロセシングの世界市場：用途別推定・予測、2020～2030年
  • 連続バイオプロセシング市場、サブセグメント分析
    • 商業
    • ワクチン
    • mAb生産
    • 組換えタンパク質生産
    • 細胞・遺伝子治療生産
    • 研究開発

第7章 連続バイオプロセシングの世界市場：エンドユーザー別

  • 市場スナップショット
  • 連続バイオプロセシングの世界市場：エンドユーザー別、実績 - ポテンシャル分析
  • 連続バイオプロセシングの世界市場：エンドユーザー別推定・予測、2020～2030年
  • 連続バイオプロセシング市場、サブセグメント分析
    • CDMO・CRO
    • 製薬・バイオテクノロジー企業
    • 学術・研究機関

第8章 連続バイオプロセシングの世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 連続バイオプロセシング市場、地域別市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • 3M Company
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Danaher Corporation
    • Thermo Fisher Scientific, Inc
    • Merck KGaA
    • Sartorius AG
    • Repligen Corporation
    • Eppendorf SE
    • Applikon Biotechnology B.V.
    • Pall Corporation
    • Bionet Co., Ltd

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Continuous Bioprocessing Market, report scope
  • TABLE 2. Global Continuous Bioprocessing Market estimates & forecasts by Region 2020-2030 (USD Million)
  • TABLE 3. Global Continuous Bioprocessing Market estimates & forecasts by Product 2020-2030 (USD Million)
  • TABLE 4. Global Continuous Bioprocessing Market estimates & forecasts by Application 2020-2030 (USD Million)
  • TABLE 5. Global Continuous Bioprocessing Market estimates & forecasts by End User 2020-2030 (USD Million)
  • TABLE 6. Global Continuous Bioprocessing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7. Global Continuous Bioprocessing Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8. Global Continuous Bioprocessing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9. Global Continuous Bioprocessing Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10. Global Continuous Bioprocessing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11. Global Continuous Bioprocessing Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12. Global Continuous Bioprocessing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13. Global Continuous Bioprocessing Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14. Global Continuous Bioprocessing Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15. Global Continuous Bioprocessing Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 16. U.S. Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 17. U.S. Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 18. U.S. Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 19. Canada Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 20. Canada Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 21. Canada Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 22. UK Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 23. UK Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 24. UK Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 25. Germany Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 26. Germany Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 27. Germany Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 28. France Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 29. France Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 30. France Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 31. Italy Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 32. Italy Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 33. Italy Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 34. Spain Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 35. Spain Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 36. Spain Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 37. RoE Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 38. RoE Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 39. RoE Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 40. China Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 41. China Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 42. China Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 43. India Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 44. India Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 45. India Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 46. Japan Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 47. Japan Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 48. Japan Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 49. South Korea Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 50. South Korea Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 51. South Korea Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 52. Australia Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 53. Australia Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 54. Australia Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 55. RoAPAC Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 56. RoAPAC Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 57. RoAPAC Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 58. Brazil Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 59. Brazil Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 60. Brazil Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 61. Mexico Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 62. Mexico Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 63. Mexico Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 64. RoLA Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 65. RoLA Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 66. RoLA Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 67. Saudi Arabia Continuous Bioprocessing Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 68. South Africa Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 69. RoMEA Continuous Bioprocessing Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Continuous Bioprocessing Market
  • TABLE 71. List of primary sources, used in the study of global Continuous Bioprocessing Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Continuous Bioprocessing Market, research methodology
  • FIG 2. Global Continuous Bioprocessing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Continuous Bioprocessing Market, key trends 2022
  • FIG 5. Global Continuous Bioprocessing Market, growth prospects 2023-2030
  • FIG 6. Global Continuous Bioprocessing Market, porters 5 force model
  • FIG 7. Global Continuous Bioprocessing Market, pest analysis
  • FIG 8. Global Continuous Bioprocessing Market, value chain analysis
  • FIG 9. Global Continuous Bioprocessing Market by segment, 2020 & 2030 (USD Million)
  • FIG 10. Global Continuous Bioprocessing Market by segment, 2020 & 2030 (USD Million)
  • FIG 11. Global Continuous Bioprocessing Market by segment, 2020 & 2030 (USD Million)
  • FIG 12. Global Continuous Bioprocessing Market by segment, 2020 & 2030 (USD Million)
  • FIG 13. Global Continuous Bioprocessing Market by segment, 2020 & 2030 (USD Million)
  • FIG 14. Global Continuous Bioprocessing Market, regional snapshot 2020 & 2030
  • FIG 15. North America Continuous Bioprocessing Market 2020 & 2030 (USD Million)
  • FIG 16. Europe Continuous Bioprocessing Market 2020 & 2030 (USD Million)
  • FIG 17. Asia pacific Continuous Bioprocessing Market 2020 & 2030 (USD Million)
  • FIG 18. Latin America Continuous Bioprocessing Market 2020 & 2030 (USD Million)
  • FIG 19. Middle East & Africa Continuous Bioprocessing Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Continuous Bioprocessing Market is valued at approximately USD 125.6 million in 2022 and is anticipated to grow with a healthy growth rate of more than 22.50% during the forecast period 2023-2030. Continuous bioprocessing refers to a method of manufacturing in the biopharmaceutical industry where the production steps for biological products occur without interruption, as opposed to traditional batch processing. The Continuous Bioprocessing Market is expanding because of factors such as the increasing number of contract development and manufacturing organizations and the rising demand for biopharmaceuticals. In a continuous bioprocessing setup, various stages of the production process, such as cell culture, harvest, purification, and formulation, are connected in a continuous flow rather than being conducted as separate, distinct batches. As a result, the demand for Continuous Bioprocessing has progressively increased in the international market during the forecast period 2023-2030.

Continuous bioprocessing has the potential to reduce overall manufacturing costs by improving resource utilization, minimizing downtime, and optimizing production processes. CDMOs, as service providers, are often focused on delivering cost-effective solutions to their clients. According to Statista, the Contract Development and Manufacturing Organization (CDMO) market accounted for USD 115.5 billion in 2020 and is projected to reach up to USD 223.5 billion by the year 2030. Another important factor that drives the Continuous Bioprocessing Market is the increasing demand for biopharmaceuticals. Continuous bioprocessing can contribute to improved product quality and consistency. Real-time monitoring and control mechanisms enhance the ability to maintain desired product attributes, reducing variability and ensuring high-quality biopharmaceuticals. In addition, as per Statista, the global pharmaceutical market accounted for USD 1.48 trillion in 2022. This represents a marginal gain from 2021 when the market was valued at USD 1.42 trillion. Moreover, the increasing number of contract development and manufacturing organizations and rising demand for biopharmaceuticals are anticipated to create lucrative growth opportunities for the market over the forecast period. However, high capital investments and stringent regulatory requirements are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Continuous Bioprocessing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the biopharmaceutical companies forming strategic partnerships and collaborations to expand their market presence in the region. The region's dominant performance is anticipated to propel the overall demand for Continuous Bioprocessing. Furthermore, Asia Pacific is expected to grow fastest over the forecast period, owing to factors such as bioprocessing technology and partnership expansions, as well as collaborations with key players in biopharma manufacturing in the region.

Major market player included in this report are:

  • 3M Company
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc
  • Merck KGaA
  • Sartorius AG
  • Repligen Corporation
  • Eppendorf SE
  • Applikon Biotechnology B.V.
  • Pall Corporation
  • Bionet Co., Ltd

Recent Developments in the Market:

  • In May 2023, 3M has allocated USD 146 million for the enhancement of its biopharma filtration technology. This substantial investment to be directed towards facility enhancements, equipment upgrades, and the recruitment of 60 full-time manufacturing employees in Europe. 3M's cutting-edge filter technology plays a crucial role in bioprocessing, biological, and small molecule pharmaceutical manufacturing. Specifically designed for customers involved in the production of biopharmaceutical drugs, these filters are instrumental in capturing impurities, ensuring the quality and purity of the pharmaceutical products.

Global Continuous Bioprocessing Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, Application, End User, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product

  • Filtration Systems and Consumables
  • Chromatography Systems and Consumables
  • Bioreactors
  • Sterilizers
  • Centrifuges
  • Others

By Application

  • Commercial
  • Vaccines
  • mAb production
  • Recombinant Protein Production
  • Cell and Gene Therapy Production
  • R&D

By End User

  • Contract Development and Manufacturing Organizations and Contract Research Organizations
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Continuous Bioprocessing Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Continuous Bioprocessing Market, by Product, 2020-2030 (USD Million)
    • 1.2.3. Continuous Bioprocessing Market, by Application, 2020-2030 (USD Million)
    • 1.2.4. Continuous Bioprocessing Market, by End User, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Continuous Bioprocessing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Continuous Bioprocessing Market Dynamics

  • 3.1. Continuous Bioprocessing Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing number of contract development and manufacturing organizations
      • 3.1.1.2. Rising demand for biopharmaceuticals
    • 3.1.2. Market Challenges
      • 3.1.2.1. High capital investments
      • 3.1.2.2. Stringent regulatory requirements
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising emergence of integrated end-to-end continuous bioprocessing
      • 3.1.3.2. Supportive government initiatives towards innovative technologies in continuous bioprocessing

Chapter 4. Global Continuous Bioprocessing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Continuous Bioprocessing Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Continuous Bioprocessing Market by Product, Performance - Potential Analysis
  • 5.3. Global Continuous Bioprocessing Market Estimates & Forecasts by Product 2020-2030 (USD Million)
  • 5.4. Continuous Bioprocessing Market, Sub Segment Analysis
    • 5.4.1. Filtration Systems and Consumables
    • 5.4.2. Chromatography Systems and Consumables
    • 5.4.3. Bioreactors
    • 5.4.4. Sterilizers
    • 5.4.5. Centrifuges
    • 5.4.6. Others

Chapter 6. Global Continuous Bioprocessing Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Continuous Bioprocessing Market by Application, Performance - Potential Analysis
  • 6.3. Global Continuous Bioprocessing Market Estimates & Forecasts by Application 2020-2030 (USD Million)
  • 6.4. Continuous Bioprocessing Market, Sub Segment Analysis
    • 6.4.1. Commercial
    • 6.4.2. Vaccines
    • 6.4.3. mAb production
    • 6.4.4. Recombinant Protein Production
    • 6.4.5. Cell and Gene Therapy Production
    • 6.4.6. R&D

Chapter 7. Global Continuous Bioprocessing Market, by End User

  • 7.1. Market Snapshot
  • 7.2. Global Continuous Bioprocessing Market by End User, Performance - Potential Analysis
  • 7.3. Global Continuous Bioprocessing Market Estimates & Forecasts by End User 2020-2030 (USD Million)
  • 7.4. Continuous Bioprocessing Market, Sub Segment Analysis
    • 7.4.1. Contract Development and Manufacturing Organizations and Contract Research Organizations
    • 7.4.2. Pharmaceutical and Biotechnology Companies
    • 7.4.3. Academic and Research Institutes

Chapter 8. Global Continuous Bioprocessing Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Continuous Bioprocessing Market, Regional Market Snapshot
  • 8.4. North America Continuous Bioprocessing Market
    • 8.4.1. U.S. Continuous Bioprocessing Market
      • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Continuous Bioprocessing Market
  • 8.5. Europe Continuous Bioprocessing Market Snapshot
    • 8.5.1. U.K. Continuous Bioprocessing Market
    • 8.5.2. Germany Continuous Bioprocessing Market
    • 8.5.3. France Continuous Bioprocessing Market
    • 8.5.4. Spain Continuous Bioprocessing Market
    • 8.5.5. Italy Continuous Bioprocessing Market
    • 8.5.6. Rest of Europe Continuous Bioprocessing Market
  • 8.6. Asia-Pacific Continuous Bioprocessing Market Snapshot
    • 8.6.1. China Continuous Bioprocessing Market
    • 8.6.2. India Continuous Bioprocessing Market
    • 8.6.3. Japan Continuous Bioprocessing Market
    • 8.6.4. Australia Continuous Bioprocessing Market
    • 8.6.5. South Korea Continuous Bioprocessing Market
    • 8.6.6. Rest of Asia Pacific Continuous Bioprocessing Market
  • 8.7. Latin America Continuous Bioprocessing Market Snapshot
    • 8.7.1. Brazil Continuous Bioprocessing Market
    • 8.7.2. Mexico Continuous Bioprocessing Market
  • 8.8. Middle East & Africa Continuous Bioprocessing Market
    • 8.8.1. Saudi Arabia Continuous Bioprocessing Market
    • 8.8.2. South Africa Continuous Bioprocessing Market
    • 8.8.3. Rest of Middle East & Africa Continuous Bioprocessing Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. 3M Company
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Danaher Corporation
    • 9.3.3. Thermo Fisher Scientific, Inc
    • 9.3.4. Merck KGaA
    • 9.3.5. Sartorius AG
    • 9.3.6. Repligen Corporation
    • 9.3.7. Eppendorf SE
    • 9.3.8. Applikon Biotechnology B.V.
    • 9.3.9. Pall Corporation
    • 9.3.10. Bionet Co., Ltd

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption